6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Endorphin System in Addiction
The endorphin system plays a vital role in regulating mood, pain, and emotional responses, and it is closely linked to the development of addiction. Endorphins are natural chemicals produced by the brain that interact with opioid receptors, helping to relieve pain and create feelings of well-being or euphoria. Addictive substances, such as alcohol, heroin, and other opioids, can artificially boost the release of endorphins, leading to intense pleasure and reinforcing the desire to continue using the substance. Over time, the brain becomes dependent on these external sources of endorphins, which can contribute to physical dependence and addiction. Understanding the endorphin system has led to treatments that target its function, including medications like naltrexone, which blocks opioid receptors and helps reduce cravings, aiding in long-term recovery from addiction.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States